Our Pre-IPO capital raising aims to bring in savvy high net worth and strategic investors who share your vision. These sophisticated investors may also add value through their own networks and experience.
We have a wealth of experience floating unlisted companies by offering shares to the public for the first time. We strategically advise you through the IPO process and help manage the after market.
An RTO may be a simpler and less costly option to raise growth capital compared to an IPO. Reverse takeovers may also offer other strategic benefits that we would be able to advise you on.
Raise further expansion capital through private placements or rights issues with our private investors. We can also find buyers for investors who wish to sell down equity stakes in their investments.
Unlock your business’ maximum value with strategic advice and analysis, capital structuring and shareholder management.
Save time by letting us help you with your ASX announcements, investor presentations, road shows and media announcements.
Gain greater growth prospects, diversification, customers and other assets through mergers and acquisitions of other businesses.
We help secure and grow your business further by sourcing new board members with fresh ideas, experience and networks.
From the beginning, Canary Capital has been avid supporters of our vision and our management team. As a start-up, there were a number of hurdles we had to overcome in our first year and it has been humbling to have the unerring support of Canary every step of the way. They have maintained ongoing communications with us, offering sound advice and professional expertise when we need it. In particular, Paul and Arun’s positive endorsement with investors has been important to the success of our business thus far.
Canary Capital has worked with Exopharm (ASX:EX1) over the past 2 years – and particularly over the past 12 months. Over that time, Canary Capital has provided us a range of services and outcomes, all at the highest professional standard. My experience with Canary Capital has been very positive and they have demonstrated capabilities that match their promises time after time. As Exopharm evolves and grows, Canary Capital continues to provide important support and advice that we can rely upon and trust.